NM_001388492.1:c.9378T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001388492.1(HTT):c.9378T>C(p.Tyr3126Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000847 in 1,601,500 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00075   (  2   hom.,  cov: 33) 
 Exomes 𝑓:  0.00086   (  1   hom.  ) 
Consequence
 HTT
NM_001388492.1 synonymous
NM_001388492.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.0670  
Publications
2 publications found 
Genes affected
 HTT  (HGNC:4851):  (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016] 
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7). 
BP6
Variant 4-3240008-T-C is Benign according to our data. Variant chr4-3240008-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1453852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000749 (114/152296) while in subpopulation AMR AF = 0.00196 (30/15308). AF 95% confidence interval is 0.00141. There are 2 homozygotes in GnomAd4. There are 50 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000749  AC: 114AN: 152178Hom.:  2  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
114
AN: 
152178
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000707  AC: 161AN: 227610 AF XY:  0.000731   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
161
AN: 
227610
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000857  AC: 1242AN: 1449204Hom.:  1  Cov.: 31 AF XY:  0.000835  AC XY: 601AN XY: 719460 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1242
AN: 
1449204
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
601
AN XY: 
719460
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
33388
American (AMR) 
 AF: 
AC: 
76
AN: 
43204
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25800
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39450
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
83638
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52354
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
5742
European-Non Finnish (NFE) 
 AF: 
AC: 
1090
AN: 
1105708
Other (OTH) 
 AF: 
AC: 
69
AN: 
59920
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.477 
Heterozygous variant carriers
 0 
 65 
 130 
 196 
 261 
 326 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 46 
 92 
 138 
 184 
 230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000749  AC: 114AN: 152296Hom.:  2  Cov.: 33 AF XY:  0.000671  AC XY: 50AN XY: 74478 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
114
AN: 
152296
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
50
AN XY: 
74478
show subpopulations 
African (AFR) 
 AF: 
AC: 
13
AN: 
41560
American (AMR) 
 AF: 
AC: 
30
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
67
AN: 
68030
Other (OTH) 
 AF: 
AC: 
4
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.517 
Heterozygous variant carriers
 0 
 6 
 12 
 17 
 23 
 29 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.